Dr. Michael David Bryant, MD

Dr. Bryant practices at Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia.

Dr. Bryant's NPI, 1558688648, was assigned on April 28, 2010. Dr. Bryant graduated from Emory School of Medicine in 2010. Dr. Bryant holds Georgia license 74154.

Dr. Bryant's primary practice is Wellstar Pulmonary Medicine - HOPD, at 55 Whitcher Street, Marietta, GA 30060.

Dr. Bryant's primary practice is Wellstar Pulmonary Medicine - HOPD in Marietta, Georgia. Dr. Bryant is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Bryant to 5 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Bryant's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bryant practices, 9 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bryant's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bryant is board certified in urology by the American Board of Urology. Dr. Bryant is licensed in Georgia.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Bryant treats.

CMS data shows 2,076 Medicare services from Dr. Bryant across 24 procedure codes in 2024, for 667 Medicare patients. Medicare paid $109,783 for them.

CMS counts 667 Medicare patients who saw Dr. Bryant in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bryant's median patient age at 74, with 25% women.

In 2024, Dr. Bryant wrote 1,850 Medicare Part D claims for 545 patients. 90% of them were for generic drugs. CMS names the drug for 1,771 of them, across 17 drugs with 11 or more claims each, at $154,108 in total drug cost. In 2023, CMS named 1,570 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Bryant for performance year 2024, reported through an alternative payment model (APM). Dr. Bryant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bryant as offering telehealth. CMS counts 19 procedures of prostate resection by Dr. Bryant, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Bryant, published from 2009 to 2012. Dr. Bryant has published most often in J Urol.

CMS Open Payments shows 250 general payments to Dr. Bryant from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Boston Scientific Corporation paid the most, $1,120.

Dr. Bryant graduated from Emory School of Medicine in 2010.

Dr. Bryant is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.